🇺🇸 FDA
Pipeline program

Genotype detected through GenSeizer high-throughput gene capture technology

K17-144

Unknown other active

Quick answer

Genotype detected through GenSeizer high-throughput gene capture technology for Non - Tuberculosis Mycobacteria Lung Disease is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Non - Tuberculosis Mycobacteria Lung Disease
Phase
Unknown
Modality
other
Status
active

Clinical trials